Claims for Patent: 6,861,058

Summary for Patent: 6,861,058

Title:	Method for treating essential tremor with botulinum toxin type B
Abstract:	A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s):	Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	09/883,122
Patent Claims:	1. A method for treating essential tremor, the method comprising the step of administering to a human patient an effective amount of a botulinum toxin type B formulation comprising sodium chloride- in order to treat essential tremor. 2. The method of claim 1, wherein the botulinum toxin type B is administered by local administration. 3. The method of claim 2, wherein the botulinum toxin type B is administered by intramuscular injection. 4. The method of claim 2, wherein the botulinum toxin type B is administered by subcutaneous injection. 5. The method of claim 1, wherein the administration of the botulinum toxin type B results in alleviation of a head or hand muscle tremor. 6. The method of claim 1, wherein the patient is administered at least about 1,000 units of the botulinum toxin type B. 7. A method for treating essential tremor, the method comprising the step of local administration to a human patient of at least 1000 units of a botulinum toxin type B formulation comprising sodium chloride, the administration of the botulinum toxin type B formulation comprising sodium chloride resulting in an alleviation of a symptom of essential tremor. 8. The method of claim 7, wherein the administration of the botulinum toxin type B results in alleviation of a head or hand muscle tremor. 9. A method for treating essential tremor the method comprising the step of intramuscular or subcutaneous administration to a human patient of at least 1000 units of a botulinum toxin type B formulation comprising sodium chloride, the administration of the botulinum toxin type B formulation comprising sodium chloride resulting in an alleviation of a symptom of essential tremor. 10. The method of claim 9, wherein the administration of the botulinum toxin type B results in alleviation of a head or hand muscle tremor.

Details for Patent 6,861,058

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Solstice Neurosciences, Llc	MYOBLOC	rimabotulinumtoxinb	Injection	103846	12/08/2000		2013-12-28